Literature DB >> 18026570

The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets.

Rodrigo Araújo Fraga-Silva1, Sergio Veloso Brant Pinheiro, Andrey Christian Costa Gonçalves, Nathalia Alenina, Michael Bader, Robson Augusto Souza Santos.   

Abstract

The antithrombotic effect of angiotensin(Ang)-(1-7) has been reported, but the mechanism of this effect is not known. We investigated the participation of platelets and receptor Mas-related mechanisms in this action. We used Western blotting to test for the presence of Mas protein in rat platelets and used fluorescent-labeled FAM-Ang-(1-7) to determine the specific binding for Ang-(1-7) and its displacement by the receptor Mas antagonist A-779 in rat platelets and in Mas(-/ -) and Mas(+/+) mice platelets. To test whether Ang-(1-7) induces NO release from platelets, we used the NO indicator DAF-FM. In addition we examined the role of Mas in the Ang-(1-7) antithrombotic effect on induced thrombi in the vena cava of male Mas(-/ -) and Mas(+/+) mice. The functional relevance of Mas in hemostasis was evaluated by determining bleeding time in Mas(+/+) and Mas(-/ -) mice. We observed the presence of Mas protein in platelets, as indicated by Western Blot, and displacement of the binding of fluorescent Ang-(1-7) to rat platelets by A-779. Furthermore, in Mas(+/+) mouse platelets we found specific binding for Ang-(1-7), which was absent in Mas(-/ -) mouse platelets. Ang-(1-7) released NO from rat and Mas(+/+) mouse platelets, and A-779 blocked this effect. The NO release stimulated by Ang-(1-7) was abolished in Mas(-/ -) mouse platelets. Ang-(1-7) inhibited thrombus formation in Mas(+/+) mice. Strikingly, this effect was abolished in Mas(-) (/) (-)mice. Moreover, Mas deficiency resulted in a significant decrease in bleeding time (8.50 +/- 1.47 vs. 4.28 +/- 0.66 min). This study is the first to show the presence of Mas protein and specific binding for Ang-(1-7) in rat and mouse platelets. Our data also suggest that the Ang-(1-7) antithrombotic effect involves Mas-mediated NO release from platelets. More importantly, we showed that the antithrombotic effect of Ang-(1-7) in vivo is Mas dependent and that Mas is functionally important in hemostasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18026570      PMCID: PMC2078558          DOI: 10.2119/2007-00073.Fraga-Silva

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  26 in total

Review 1.  Angiotensin-(1-7): an update.

Authors:  R A Santos; M J Campagnole-Santos; S P Andrade
Journal:  Regul Pept       Date:  2000-07-28

2.  Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).

Authors:  Iwona Kucharewicz; Robert Pawlak; Tomasz Matys; Dariusz Pawlak; Wlodzimierz Buczko
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

Review 3.  Angiotensin-(1-7): an active member of the renin-angiotensin system.

Authors:  I Kucharewicz; R Pawlak; T Matys; E Chabielska; W Buczko
Journal:  J Physiol Pharmacol       Date:  2002-12       Impact factor: 3.011

Review 4.  Nitric oxide insufficiency, platelet activation, and arterial thrombosis.

Authors:  J Loscalzo
Journal:  Circ Res       Date:  2001-04-27       Impact factor: 17.367

Review 5.  Endothelial nitric oxide synthase (eNOS) in platelets: how is it regulated and what is it doing there?

Authors:  Voahanginirina Randriamboavonjy; Ingrid Fleming
Journal:  Pharmacol Rep       Date:  2005       Impact factor: 3.024

Review 6.  Role of platelets in thrombosis and hemostasis.

Authors:  M A Packham
Journal:  Can J Physiol Pharmacol       Date:  1994-03       Impact factor: 2.273

7.  Serotonin deficiency and prolonged bleeding in beige mice.

Authors:  J M Holland
Journal:  Proc Soc Exp Biol Med       Date:  1976-01

8.  Impaired activation of murine platelets lacking G alpha(i2).

Authors:  H M Jantzen; D S Milstone; L Gousset; P B Conley; R M Mortensen
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

9.  Angiotensin II receptors on human platelets.

Authors:  T J Moore; G H Williams
Journal:  Circ Res       Date:  1982-09       Impact factor: 17.367

Review 10.  Platelets and cardiovascular disease.

Authors:  Scott Willoughby; Andrew Holmes; Joseph Loscalzo
Journal:  Eur J Cardiovasc Nurs       Date:  2002-12       Impact factor: 3.908

View more
  53 in total

1.  Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Janae Joyner; Jasmina Varagic
Journal:  Adv Pharmacol       Date:  2010

Review 2.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 3.  Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.

Authors:  Sadashiva S Karnik; Khuraijam Dhanachandra Singh; Kalyan Tirupula; Hamiyet Unal
Journal:  Br J Pharmacol       Date:  2017-03-09       Impact factor: 8.739

Review 4.  ACE2: more of Ang-(1-7) or less Ang II?

Authors:  Carlos M Ferrario
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-01       Impact factor: 2.894

Review 5.  New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism.

Authors:  Carlos M Ferrario
Journal:  Hypertension       Date:  2009-12-21       Impact factor: 10.190

6.  125I-Angiotensin 1-7 binds to a different site than angiotensin 1-7 in tissue membrane preparations.

Authors:  Filipe F Stoyell-Conti; Sarin Itty; Christy Abraham; Katya Rigatto; Crystal A West; Robert C Speth
Journal:  Endocrine       Date:  2021-01-07       Impact factor: 3.633

7.  Local angiotensin-(1-7) administration improves microvascular endothelial function in women who have had preeclampsia.

Authors:  Anna E Stanhewicz; Lacy M Alexander
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-02       Impact factor: 3.619

8.  Hypertensive urgencies and emergencies: Misconceptions and pitfalls.

Authors:  Fabio Angeli; Gianpaolo Reboldi; Paolo Verdecchia
Journal:  Eur J Intern Med       Date:  2019-11-06       Impact factor: 4.487

9.  Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation.

Authors:  Chao Fang; Evi Stavrou; Alec A Schmaier; Nadja Grobe; Mariana Morris; Andrew Chen; Marvin T Nieman; Gregory N Adams; Gretchen LaRusch; Yihua Zhou; Matthew L Bilodeau; Fakhri Mahdi; Mark Warnock; Alvin H Schmaier
Journal:  Blood       Date:  2013-02-05       Impact factor: 22.113

Review 10.  Opportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension.

Authors:  Rodrigo Araujo Fraga-Silva; Anderson Jose Ferreira; Robson Augusto Souza Dos Santos
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.